Olongapo hits herd immunity target vs COVID-19 | Inquirer News

Olongapo hits herd immunity target vs COVID-19

Olongapo hits herd immunity target vs COVID-19.

Most of the quarantine restrictions in Olongapo City have been relaxed after being placed under the most lenient Alert Level 1 and achieving the herd immunity target against COVID-19. (File photo by Joanna Rose Aglibot)

OLONGAPO CITY — The city has achieved herd immunity against COVID-19 after the number of fully vaccinated residents already surpassed the target, local data showed on Thursday, March 3.

According to the city’s COVID-19 task force, at least 191, 825 residents here have completed their primary series of the vaccine since the local government began its mass inoculation in the middle of 2021.


The figure represents 105 percent of the target eligible population of 182,000, data showed.


Hitting the target came amid the improving COVID-19 situation in the city, with only 14 active cases left as of Thursday.

At least 29, 312 residents have also received their booster shots as the City Health Office continues to conduct mass vaccinations, including those for children 5 years old and above.

The city has 260,000 population based on the 2020 census.


Olongapo City lifts curfew under Alert Level 1

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo City

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.